Dear Reader,
With almost two decades under its belt, Fierce Biotech's Fierce 15 boasts more than 250 alumni — and those biotechs know a thing or two about taking a company from startup mode to full-fledged public company. And now, we've gathered Fierce 15 executives to share those hard-won insights in a webinar series you won't want to miss.
Join us as we discuss this and more during our upcoming FIERCE BIOTECH VIRTUAL SERIES – How to Grow: Insights from Fierce 15 Alumni. We’ll bring you insights from top experts about venture capital, going public, finding partners and running successful trials.
Monday, October 5:
- VC, M&A and IPO: The Funding Game and Investor Strategy
Tuesday, October 6:
- Strategies to Avoid Enrollment Delays
- Overcoming Challenges in Midstage Trials, from Clinic to Supply
Wednesday, October 7:
- Partnering in Phase 3: The Big Leap to Big Trials
I hope you will join us for the FIERCE BIOTECH VIRTUAL SERIES – How to Grow: Insights from Fierce 15 Alumni. Reserve your spot and register for free today.
 | Rebecca Willumson |
